Use of heparinase modified thrombelastography in liver transplantation.

Severe coagulopathies can occur during liver transplantation, particularly after reperfusion of the grafted liver. Heparin release has been proposed as one of the factors contributing to this coagulopathy. We have analysed the thrombelastograph (TEG) traces of 55 patients after reperfusion using native and heparinase-treated samples. In almost all cases an abnormal native TEG was improved in vitro by heparinase, demonstrating the presence of heparin or a heparin-like substance. The heparinase-modified TEG allowed assessment of the underlying coagulation status, providing a rational guide to blood component replacement or treatment of fibrinolysis.

[1]  M. Bracher,et al.  Heparin as the cause of coagulopathy which may complicate grafting of the liver. , 1991, Surgery, gynecology & obstetrics.

[2]  M. Thick,et al.  Reversal of post-reperfusion coagulopathy by protamine sulphate in orthotopic liver transplantation. , 1994, British journal of anaesthesia.

[3]  J. Najarian,et al.  Reperfusion coagulopathy during human liver transplantation. , 1987, Transplantation proceedings.

[4]  O. Garden,et al.  Plasma concentrations of endogenous heparinoids in portal hypertension. , 1992, Gut.

[5]  Yoogoo Kang,et al.  Thromboelastography in Liver Transplantation , 1995, Seminars in Thrombosis & Hemostasis.

[6]  J H Lewis,et al.  Intraoperative Changes in Blood Coagulation and Thrombelastographic Monitoring in Liver Transplantation , 1985, Anesthesia and analgesia.

[7]  H. Riess,et al.  Soluble thrombomodulin levels during orthotopic liver transplantation. , 1993, Seminars in thrombosis and hemostasis.

[8]  R. McCarthy,et al.  Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay. , 1994, Journal of cardiothoracic and vascular anesthesia.

[9]  C. Dietrich,et al.  Sequential degradation of heparin in Flavobacterium heparinum. Purification and properties of five enzymes involved in heparin degradation. , 1973, The Journal of biological chemistry.

[10]  O. Terpstra,et al.  THE APPEARANCE OF DONOR HEPARIN IN THE RECIPIENT AFTER REPERFUSION OF A LIVER GRAFT , 1993, Transplantation.

[11]  K. Hardy,et al.  Patterns of Coagulopathy during Liver Transplantation: Experience with the First 75 Cases using Thrombelastography , 1994, Anaesthesia and intensive care.